Role of glucosamine in development of diabetic neuropathy independent of the aldose reductase pathway.
Ontology highlight
ABSTRACT: Long-term metabolic aberrations contribute to the development of diabetic neuropathy but the precise mechanism or mechanisms remains elusive. We have previously shown that aldose reductase-deficient mice exhibit delayed onset and progression of neuropathy following induction of diabetes, suggesting a role both for downstream metabolites of this enzyme and also for other unrelated pathways. In this study, we have utilized comprehensive metabolomics analyses to identify potential neurotoxic metabolites in nerve of diabetic mice and explored the mechanism of peripheral nerve injury. Aldose reductase knockout and control C57Bl/6J mice were made diabetic by injection of streptozotocin and followed for 8-16 weeks. Diabetic aldose reductase knockout mice exhibited delayed onset of nerve conductio
SUBMITTER: Mizukami H
PROVIDER: S-EPMC7713992 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature
ACCESS DATA